Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity

Aims. The aim of this study is to examine the efficacy of adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with type 2 diabetes inadequately controlled by metformin and sulphonylurea combination treatment. The response of Asian and non-Asian patients to this regimen was also examined. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, X., Brooks, B., Molyneaux, L., Landy, E., Banatwalla, R., Wu, T., Wong, J., Su, B., Yue, D. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142741/
https://www.ncbi.nlm.nih.gov/pubmed/25180036
http://dx.doi.org/10.1155/2014/354040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142741/
https://www.ncbi.nlm.nih.gov/pubmed/25180036
http://dx.doi.org/10.1155/2014/354040

Ejemplares similares